Inventor · disambiguated record
Pier Giovanni Baraldi
Also filed as: BARALDI PIER G · BARALDI PIER GIOVANNI
39 granted patents·10 pending applications·525 citations·filing 1995–2013
98Inventor score
Files withKING PHARMACEUTICALS RES & DEV16BARALDI PIER GIOVANNI5MEDCO RES INC4PHARMESTE SRL4PHARMACIA & UPJOHN SPA3
Top patents by PatentIndex Score
49 records- 0189US6358964B1Adenosine, A3 receptor modulatorsKING PHARMACEUTICALS RES & DEV·Filed 2000·Granted Mar 19, 2002·22 cites·18 claims
- 0287US6407236B1Adenosine A3 receptor modulatorsMEDCO RES INC·Filed 1999·Granted Jun 18, 2002·68 cites·43 claims
- 0385US6727258B2Allosteric adenosine receptor modulatorsKING PHARMACEUTICAL RES & DEV·Filed 2001·Granted Apr 27, 2004·22 cites·11 claims
- 0484US7205403B28-Heteroaryl xanthine adenosine A2B receptor antagonistsKING PHARMACEUTICALS RES & DEV·Filed 2003·Granted Apr 17, 2007·18 cites·32 claims
- 0583US7470698B2Adenosine A3 receptor modulatorsKING PHARMACEUTICALS RES & DEV·Filed 2007·Granted Dec 30, 2008·4 cites·4 claims
- 0682US7271171B2Adenosine A3 receptor modulatorsKING PHARMACEUTICALS RES & DEV·Filed 2005·Granted Sep 18, 2007·4 cites·29 claims
- 0780US6326390B1Use of adenosine A3 receptor antagonists to inhibit tumor growthKING PHARMACEUTICALS RESEACH A·Filed 1999·Granted Dec 4, 2001·64 cites·39 claims
- 0878US5935964A1,2,4-triazolo 1,5-c! pyrimidine heterocyclic analogues having antagonistic activity on adenosine A2a receptorSCHERING CORP·Filed 1996·Granted Aug 10, 1999·35 cites·9 claims
- 0977US7919624B2VR1 vanilloid receptor antagonists with a iononic substructurePHARMESTE SRL·Filed 2007·Granted Apr 5, 2011·5 cites·27 claims
- 1077US7511133B2Adenosine A3 receptor agonistsKING PHARMACEUTICALS RES & DEV·Filed 2004·Granted Mar 31, 2009·10 cites·1 claims
- 1177US7112607B2Allosteric adenosine receptor modulatorsKING PHARMACEUTICALS RES & DEV·Filed 2002·Granted Sep 26, 2006·7 cites·8 claims
- 1276US7335655B28-heteroaryl xanthine adenosine A2B receptor antagonistsKING PHARMACEUTICALS RES & DEV·Filed 2006·Granted Feb 26, 2008·2 cites·10 claims
- 1376US6323214B1Allosteric adenosine receptor modulatorsMEDCO RES INC·Filed 1998·Granted Nov 27, 2001·38 cites·9 claims
- 1476US5753629ADistamycin A analogues as antitumour or antiviral agentsPHARMACIA SPA·Filed 1995·Granted May 19, 1998·41 cites·12 claims
- 1575US6048865AN6 -substituted-adenosine-5'-uronamides as adenosine receptor modulatorMEDCO RES INC·Filed 1998·Granted Apr 11, 2000·44 cites·15 claims
- 1673US6921825B2Adenosine A3 receptor modulatorsKING PHARMACEUTICUALS RES & DE·Filed 2002·Granted Jul 26, 2005·8 cites·8 claims
- 1773US5939432AThiophenes useful for modulating the adenosine receptorMEDCO RES INC·Filed 1997·Granted Aug 17, 1999·26 cites·5 claims
- 1872US7767685B2Adenosine A2B receptor antagonistsKING PHARMACEUTICALS RES & DEV·Filed 2007·Granted Aug 3, 2010·2 cites·7 claims
- 1972US7435740B2Adenosine A3 receptor modulatorsKING PHARMACEUTICALS RES & DEV·Filed 2006·Granted Oct 14, 2008·3 cites·18 claims
- 2071US6458768B1Benzoheterocyclic distamycin derivatives, process for preparing them, and their use as antitumor agentsPHARMACIA & UPJOHN SPA·Filed 1999·Granted Oct 1, 2002·15 cites·7 claims
- 2171US6153642ABenzoheterocyclic distamycin derivatives, process for preparing them, and their use as antitumor and antiviral agentsPHARMACIA & UPJOHN SPA·Filed 1997·Granted Nov 28, 2000·16 cites·10 claims
- 2270US7094895B2Tyrosyl derivatives and their use as P2X7 receptor modulatorsKING PHARMACEUTICALS RES & DEV·Filed 2002·Granted Aug 22, 2006·4 cites·7 claims
- 2369US7064204B2Pharmaceutically active compounds having a tricyclic pyrazolotriazolopyrimidine ring structure and methods of useKING PHARMACUETICALS RESERCH A·Filed 2003·Granted Jun 20, 2006·7 cites·3 claims
- 2468US7101905B2Pharmaceutically active compounds and methods of useKING PHARMACEUTICALS RES & DEV·Filed 2002·Granted Sep 5, 2006·4 cites·8 claims
- 2568US6177444B1Allosteric adenosine receptor modulatorsMEDCO CORP·Filed 1999·Granted Jan 23, 2001·21 cites·9 claims
- 2666US6448253B1Adenosine A3 receptor modulatorsKING PHARMACEUTICALS RES & DEV·Filed 1998·Granted Sep 10, 2002·20 cites·19 claims
- 2764US9278958B2Anti-cancer compoundsUNIV LEUVEN KATH·Filed 2013·Granted Mar 8, 2016·1 cites·24 claims
- 2862US6194449B1Allosteric adenosine receptor modulatorsMEDCO CORP·Filed 1999·Granted Feb 27, 2001·14 cites·6 claims
- 2957US2009203719A1Enhancing treatment of mdr cancer with adenosine a3 antagonistsBOREA PIER ANDREA·Filed 2008·Application pending·0 cites
- 3056US7855209B2Allosteric modulators of the A1 adenosine receptorKING PHARMACEUTICALS RES & DEV·Filed 2007·Granted Dec 21, 2010·0 cites·21 claims
- 3154US2004077630A1Allosteric adenosine receptor modulatorsFiled 2003·Application pending·0 cites
- 3252US7449490B2Pharmaceutically active compounds and methods of useKING PHARMACEUTICALS RES & DEV·Filed 2006·Granted Nov 11, 2008·0 cites·9 claims
- 3351US2005119289A1Enhancing treatment of MDR cancer with adenosine A3 antagonistsFiled 2003·Application pending·0 cites
- 3451US2009281145A1Allosteric enhancers of the a1 adenosine receptorBARALDI PIER GIOVANNI·Filed 2009·Application pending·0 cites
- 3549US2004067932A1Enhancing treatment of MDR cancer with adenosine A3 antagonistsFiled 2003·Application pending·0 cites
- 3647US7964642B2Vanilloid TRPV1 receptor antagonistsPHARMESTE SRL·Filed 2005·Granted Jun 21, 2011·0 cites·7 claims
- 3747US7897596B2Allosteric modulators of the A1 adenosine receptorKING PHARMACEUTICALS RES & DEV·Filed 2007·Granted Mar 1, 2011·0 cites·25 claims
- 3847US2006204502A1Enhancing treatment of cancer and HIF-1 mediated disorders with adenosine A3 receptor antagonistsBOREA PIER A·Filed 2005·Application pending·0 cites
- 3947US2006194756A1Enhancing treatment of HIF-1 mediated disorders with adenosine A3 receptor agonistsBOREA PIER A·Filed 2005·Application pending·0 cites
- 4046US8222275B2Biarylcarboxyarylamides as vanilloid-1 receptor modulatorsBARALDI PIER GIOVANNI·Filed 2007·Granted Jul 17, 2012·0 cites·27 claims
- 4146US7691825B2Adenosine A2B receptor agonistsKING PHARMACEUTICALS RES & DEV·Filed 2007·Granted Apr 6, 2010·0 cites·11 claims
- 4244US7750049B2O-substituted-dibenzyl urea-derivatives as TRPV1 receptor antagonistsPHARMESTE SRL·Filed 2007·Granted Jul 6, 2010·0 cites·18 claims
- 4343US7396851B2Heterocyclic and benzoheterocyclic polyamides structurally related to the natural antibiotic distamycin A for the treatment of β-thalassaemiaUNIV FERRARA·Filed 2002·Granted Jul 8, 2008·0 cites·14 claims
- 4443US2009233878A1Novel adenosine a3 receptor agonistsBARALDI PIER GIOVANNI·Filed 2008·Application pending·0 cites
- 4542US7579378B2Sulfonamido compounds that antagonize the vanilloid TRPV1 receptorPHARMESTE SRL·Filed 2005·Granted Aug 25, 2009·0 cites·23 claims
- 4639US2012108636A1Allosteric Enhancers of th A1 Adenosine ReceptorBARALDI PIER GIOVANNI·Filed 2012·Application pending·0 cites
- 4736US2011053917A1Allosteric Modulators of the A1 Adenosine ReceptorBARALDI PIER GIOVANNI·Filed 2010·Application pending·0 cites
- 4830US6753316B1Acryloyl derivatives analogous to distamycin, process for preparing them, and their use as antitumor agentsPHARMACIA & UPJOHN SPA·Filed 1999·Granted Jun 22, 2004·0 cites·8 claims
- 4927US6596845B1Cinnamoyl distamycin analogous derivatives, process for their preparation, and their use as antitumor agentsPHARMACIA ITALIA SPA·Filed 1999·Granted Jul 22, 2003·0 cites·14 claims
Join the waitlist — get patent alerts
Get an alert when Pier Giovanni Baraldi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →